Among the 4 types of cancers selected previously, ptpn6 alteration frequency was relatively higher in UCS, TGCT and LGG, and the highest alteration frequency was observed in UCS patients, mainly characterized by “amplification” and “multiple alterations” (Fig. 7A). This evidence concerns the gene PTPN6 and cancer.